ONL Therapeutics
Biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD402—603m (Dealroom.co estimates Sep 2024.)
Ann Arbor Michigan (HQ)
Authorizing premium user...